My watch list
my.bionity.com  
Login  

7 Current news of Sangamo BioSciences

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

Sangamo completes acquisition of TxCell

04-Dec-2018

Sangamo Therapeutics, Inc. announced the completion of the acquisition of TxCell, SA. TxCell is now a subsidiary of Sangamo and has been delisted from the French stock market. “The acquisition of TxCell immediately positions Sangamo as the leader in CAR-Treg development,” said Sandy Macrae, CEO ...

more

Sangamo Therapeutics to acquire TxCell

24-Jul-2018

Sangamo Therapeutics and TxCell announced that they have entered into a definitive agreement on July 20, 2018 pursuant to which Sangamo will, following the completion of the contemplated acquisition of a majority stake of TxCell, file a simplified cash tender offer for the purchase of all then ...

more

Sigma-Aldrich and Sangamo BioSciences Announce Alliance to Develop Zinc Finger-Based Laboratory Research Reagents

13-Jul-2007

Sigma-Aldrich Corporation and Sangamo BioSciences, Inc. announced a significant alliance focused on the development of high value laboratory research reagents based upon Sangamo's ZFP technology. The alliance combines Sigma's global marketing capabilities and reputation as a provider of high ...

more

Dow AgroSciences and Sangamo BioSciences Announce the Achievement of Multiple Milestones in Plant Agriculture Collaboration

20-Nov-2006

Dow AgroSciences LLC and Sangamo BioSciences, Inc. announced the successful completion of multiple research milestones as part of their Research and Commercial License Agreement initiated October 2005. The three-year agreement provides Dow AgroSciences with access to Sangamo's proprietary zinc ...

more

Dow AgroSciences, Sangamo BioSciences Announce Research and Commercial License Agreement in Plant Agriculture

07-Oct-2005

Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company, and Sangamo BioSciences, Inc. announced the signing of a Research and Commercial License Agreement. The agreement provides Dow AgroSciences with access to Sangamo's proprietary zinc finger DNA-binding protein (ZFP) ...

more

Novo Nordisk and Sangamo BioSciences Announce Agreement

12-Sep-2005

Novo Nordisk A/S and Sangamo BioSciences, Inc. announced an agreement that provides Novo Nordisk with access to Sangamo's proprietary zinc finger DNA-binding protein (ZFP) technology. Sangamo will provide its ZFP technology for Novo Nordisk to evaluate for use in the field of enhanced protein ...

more

Sangamo BioSciences Receives $2 Million Advanced Technology Program

Third ATP Grant Awarded to Company

05-May-2004

Richmond, Calif. -- Sangamo BioSciences, Inc. announced that the company has been awarded an Advanced Technology Program (ATP) grant to conduct research on a novel application of Sangamo's zinc finger DNA binding protein transcription factor (ZFP TF) technology. The grant, worth $2 million, was ...

more

Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE